Complementary Predictors for Asthma Attack Prediction in Children: Salivary Microbiome, Serum Inflammatory Mediators, and Past Attack History

Serum inflammatory mediators and salivary microbiome complement asthma attacks history for predicting future attacks. These results highlight the imperative for continued investigation into oral microbiota and its interaction with the immune system.

Authors

Institutions

Publication Details

Journal
Allergy
Published
2025-08-18
DOI
https://doi.org/10.1111/all.70004
Citations
3
Primary Topic
Asthma and respiratory diseases
Type
article
Field-Weighted Citation Impact
3.49

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Complementary Predictors for Asthma Attack Prediction in Children: Salivary Microbiome, Serum Inflammatory Mediators, and Past Attack History

Peter Sterk, Susanne Harner, Jonathan Thorsen, Klaus Bønnelykke et al.
3 citations
Allergy
Asthma and respiratory diseases
3.49
article

Complementary Predictors for Asthma Attack Prediction in Children: Salivary Microbiome, Serum Inflammatory Mediators, and Past Attack History

Peter Sterk, Susanne Harner, Jonathan Thorsen, Klaus Bønnelykke, Corinna Bang, Simone Hashimoto, Stephen James Fowler, Louise Fleming, Bo Chawes, Suzanne W. J. Terheggen‐Lagro, Mahmoud I. Abdel‐Aziz, Mario Gorenjak, Uroš Potočnik, Anke H. Maitland‐van der Zee, Olaia Sardón‐Prado, Anne H. Neerincx, Aruna T. Bansal, Sven‐Erik Dahlén, Susanne J. H. Vijverberg, Antoaneta A. Toncheva, Søren Johannes Sørensen, Dominick Shaw, Gunilla Hedlin, Jakob Stokholm, Paula Corcuera, Kian Fan Chung, Heike Buntrock‐Döpke, Paul Brinkman, Alexander Kiefer, Ratko Djukanović, Florian Singer, René Lutter, JanWillem Duitman, Aletta D. Kraneveld, Maria Pino‐Yanes, Susanne Brandstetter, Charles Auffray, Nazanin Zounemat Kermani, Barbara Smids, Urs Frey, Clare Murray, Shahriyar Shahbazi Khamas, Andrew Bush, Ian Michael Adcock, Christine Wolff, Michael Kabesch, Graham Roberts, Jelle M. Blankestijn, Jon R. Konradsen, André Franke, Nadja Hawwa Vissing, Björn Nordlund, Eric G. Haarman, Leyre López‐Fernández, Tamara Dekker, Nariman K. A. Metwally, Ana R. Sousa, Fleur Sondaal, Parastoo Kheirolldein
article en
3 citations

Abstract

Serum inflammatory mediators and salivary microbiome complement asthma attacks history for predicting future attacks. These results highlight the imperative for continued investigation into oral microbiota and its interaction with the immune system.

AllergyVol. 81(2)
Université Claude Bernard Lyon 1 (FR), University of Bern (CH), University of Copenhagen (DK), Centre National de la Recherche Scientifique (FR), Karolinska University Hospital (SE), Inserm (FR), Universidad de La Laguna (ES), St. John's College of Nursing (US), University of the Basque Country (ES), University of Basel (CH), GlaxoSmithKline (United Kingdom) (GB), Utrecht University (NL), Medical University of Graz (AT), Manchester Academic Health Science Centre (GB), University Hospital of Bern (CH), Instituto de Salud Carlos III (ES), Harefield Hospital (GB), University Hospital Southampton NHS Foundation Trust (GB), Karolinska Institutet (SE), University of Manchester (GB), University Hospital Regensburg (DE), Christian-Albrechts-Universität zu Kiel (DE), University of Maribor (SI), University College Copenhagen (DK), Emma Kinderziekenhuis (NL), Royal Brompton Hospital (GB), Biogipuzkoa Health Research Institute (ES), Amsterdam Neuroscience (NL), NIHR Southampton Biomedical Research Centre (GB), Copenhagen Prospective Studies on Asthma in Childhood (DK), University Children’s Hospital Basel (CH), University Clinical Centre Maribor (SI), GGD Amsterdam (NL), Amsterdam University Medical Centers (NL), Centre International de Recherche en Infectiologie (FR), NIHR Leicester Biomedical Research Centre (GB), European Institute for Systems Biology and Medicine, Imperial College London (GB), Amsterdam University of Applied Sciences (NL), IT University of Copenhagen (DK), University of Amsterdam (NL)
Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, Chiesi Farmaceutici, Universität Basel, University of Bern, Regeneron Pharmaceuticals, University Hospital Southampton NHS Foundation Trust, Vertex Pharmaceuticals, European Federation of Pharmaceutical Industries and Associations, Universidad de La Laguna, Inselspital, Universitätsspital Bern, Celltrion, Amsterdam University Medical Centers, GlaxoSmithKline España, National Institute for Health and Care Research, Asthma and Lung UK, University of Leicester, University of Southampton, Imperial College London, European Commission, Institut National de la Santé et de la Recherche Médicale, ZonMw, Universiteit van Amsterdam, Universiteit Utrecht, Bundesministerium für Bildung und Forschung, Gentofte Hospital, Euskal Herriko Unibertsitatea, Karolinska Institutet, Novo Nordisk, Javna Agencija za Raziskovalno Dejavnost RS, Stichting Astma Bestrijding, Stockholms Läns Landsting, Centre National de la Recherche Scientifique, Universität Regensburg, Ministrstvo za Izobraževanje, Znanost in Šport, Université Claude Bernard Lyon 1, Karl-Franzens-Universität Graz, Univerza v Mariboru, Medizinische Universität Graz, European Academy of Allergy and Clinical Immunology, Univerzitetni Klinični Center Maribor, Directorate for Biological Sciences, Novartis Pharma, Seventh Framework Programme, Medical Research Council, Engineering and Physical Sciences Research Council, Instituto de Salud Carlos III, Institute of Infection and Immunity, FP7 Health
Life in Land
Openalex Percentile: Top 7%
Asthma and respiratory diseases
3.49
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.